ArcticZymes Technologies ASA (OSL:AZT)

Market Cap	1.35B
Revenue (ttm)	104.33M
Net Income (ttm)	2.80M
Shares Out	51.07M
EPS (ttm)	0.05
PE Ratio	482.84
Forward PE	89.47
Dividend	n/a
Ex-Dividend Date	n/a

Volume	169,721
Average Volume	75,832
Open	26.10
Previous Close	25.20
Day's Range	25.00 - 27.50
52-Week Range	12.34 - 27.40
Beta	0.50
RSI	81.39
Earnings Date	Aug 14, 2025

About OSL:AZT

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing. The company offers shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays for the removal of contaminating dU-DNA; salt active nucleases for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1990
• Employees: 54
• Stock Exchange: Oslo Børs
• Ticker Symbol: AZT

Financial Performance

In 2024, OSL:AZT's revenue was 108.11 million, a decrease of -9.65% compared to the previous year's 119.65 million. Earnings were 8.47 million, a decrease of -56.40%.